Anti-infective Ophthalmic Market is expected to reach 1520 million US$ by 2025 – QY Research


Posted August 14, 2018 by sayaliqy

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business

 
​This report studies the global market size of Anti-infective Ophthalmic in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-infective Ophthalmic in these regions.

This research report categorizes the global Anti-infective Ophthalmic market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.

In terms of region, the global ophthalmic anti-infective market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global ophthalmic anti-infective market due to availability of advanced drug formulations in the region. Awareness among people about diseases is also a major factor boosting the market in the region. The ophthalmic anti-infective market in Asia Pacific is anticipated to expand at a rapid pace due to increase in incidence of eye infection in the region. Lack of awareness about diseases and unavailability of advanced medication and formulations in underdeveloped countries, such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the ophthalmic anti-infective market in Middle East & Africa.

In 2017, the global Anti-infective Ophthalmic market size was 1410 million US$ and is forecast to 1520 million US in 2025, growing at a CAGR of 1.0% from 2018. The objectives of this study are to define, segment, and project the size of the Anti-infective Ophthalmic market based on company, product type, application and key regions.

The various contributors involved in the value chain of Anti-infective Ophthalmic include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-infective Ophthalmic include

Novartis

Allergan

Valeant Pharmaceuticals

Santen Pharmaceutical

Lupin Pharmaceuticals

Apotex

Akorn

Request Sample Copy of [email protected] https://www.qyresearch.com/sample-form/form/660744/global-anti-infective-ophthalmic-market

Market Size Split by Type

Antibacterial

Antiviral

Antifungal

Anti-parasitic

Others

Market Size Split by Application

Hospital Use

Clinic Use

Household

Other

Request to Buy Full [email protected] https://www.qyresearch.com/settlement/pre/a906b21c1ba06fc3410f6fb87c656256,0,1
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By sayali
Country United States
Categories Baby , Business , Health
Last Updated August 14, 2018